Natural Beauty Bio-Technology Limited
Natural Beauty Bio-Technology Limited, an investment holding company, provides skin care products and services in Mainland China, Taiwan, and internationally. It manufactures and sells skin care, beauty, aroma-therapeutic, and make-up products, as well as health supplements under the Natural Beauty brand. The company also offers skin treatments, beauty services, medical cosmetology services, and … Read more
Natural Beauty Bio-Technology Limited (NBBTF) - Total Liabilities
Latest total liabilities as of June 2025: $367.05 Million USD
Based on the latest financial reports, Natural Beauty Bio-Technology Limited (NBBTF) has total liabilities worth $367.05 Million USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Natural Beauty Bio-Technology Limited - Total Liabilities Trend (2001–2024)
This chart illustrates how Natural Beauty Bio-Technology Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Natural Beauty Bio-Technology Limited Competitors by Total Liabilities
The table below lists competitors of Natural Beauty Bio-Technology Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Starbreeze AB (publ)
PINK:STBEF
|
USA | $120.21 Million |
|
Arcario AB
ST:ARCA
|
Sweden | Skr15.02 Million |
|
Chungdamglobal Co. Ltd.
KQ:362320
|
Korea | ₩97.11 Billion |
|
Rimbunan Sawit Bhd
KLSE:5113
|
Malaysia | RM390.61 Million |
|
Finnovate Acquisition Corp
NASDAQ:FNVT
|
USA | $4.58 Million |
|
Hi Sharp Electronics Co Ltd
TWO:3128
|
Taiwan | NT$1.12 Billion |
|
Ssangyong Information & Communications Corp
KQ:010280
|
Korea | ₩247.88 Billion |
|
Long Time Technology Co., Ltd.
TWO:6555
|
Taiwan | NT$623.68 Million |
Liability Composition Analysis (2001–2024)
This chart breaks down Natural Beauty Bio-Technology Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.45 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.76 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.43 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Natural Beauty Bio-Technology Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Natural Beauty Bio-Technology Limited (2001–2024)
The table below shows the annual total liabilities of Natural Beauty Bio-Technology Limited from 2001 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $325.34 Million | +5.61% |
| 2023-12-31 | $308.06 Million | +7.69% |
| 2022-12-31 | $286.07 Million | +2.44% |
| 2021-12-31 | $279.24 Million | +21.65% |
| 2020-12-31 | $229.54 Million | +14.57% |
| 2019-12-31 | $200.34 Million | +57.61% |
| 2018-12-31 | $127.11 Million | -0.02% |
| 2017-12-31 | $127.14 Million | -24.10% |
| 2016-12-31 | $167.51 Million | +7.40% |
| 2015-12-31 | $155.97 Million | -23.48% |
| 2014-12-31 | $203.82 Million | +5.17% |
| 2013-12-31 | $193.81 Million | +42.44% |
| 2012-12-31 | $136.06 Million | -20.17% |
| 2011-12-31 | $170.44 Million | +7.67% |
| 2010-12-31 | $158.30 Million | +21.31% |
| 2009-12-31 | $130.49 Million | -23.16% |
| 2008-12-31 | $169.82 Million | +45.56% |
| 2007-12-31 | $116.66 Million | -1.54% |
| 2006-12-31 | $118.49 Million | +1.12% |
| 2005-12-31 | $117.17 Million | +22.57% |
| 2004-12-31 | $95.60 Million | +18.28% |
| 2003-12-31 | $80.83 Million | -24.48% |
| 2002-12-31 | $107.03 Million | -35.08% |
| 2001-12-31 | $164.88 Million | -- |